Company / Free Cash Flow
Wave Life Sciences Ltd. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$188.2M
FY2025
5-year range
-$188.2M / -$20.5M
FY2021-FY2025
Trend
-23.9%
vs FY2024
Sector context
#146 of 194
Health Care
What the data says
Wave Life Sciences Ltd.'s free cash flow of -$188M is lower than 75% of companies in the Health Care sector (FY2025). Free Cash Flow has fluctuated over the past 10 years, ranging from -$192M in FY2020 to -$21M in FY2023.
Based on SEC 10-K filings.
-$188M in FY2025.
Declined from -$21M to -$188M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 194This company -$188.2M Sector average $470.6M
▼
-140.0% below sector average
Key checks
Key Insights
- In FY2025, free cash flow decreased 23.9% year-over-year.
- Ranks #146 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2023.
- Lowest free cash flow in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$188.2M | -23.9% |
| FY2024 | -$152.0M | -639.6% |
| FY2023 | -$20.5M | +77.1% |
| FY2022 | -$89.6M | +23.7% |
| FY2021 | -$117.3M | +38.9% |
| FY2020 | -$192.1M | -87.4% |
| FY2019 | -$102.6M | -212.7% |
| FY2018 | -$32.8M | +68.0% |
| FY2017 | -$102.6M | -173.5% |
| FY2016 | -$37.5M | -942.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026